KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,023 | +23.5% | 12,379 | +0.0% | 0.00% | – |
| Q2 2023 | $174,133 | +30.6% | 12,376 | 0.0% | 0.00% | – |
| Q1 2023 | $133,288 | -99.1% | 12,376 | -98.9% | 0.00% | -100.0% |
| Q2 2021 | $15,271,000 | -26.8% | 1,096,252 | -2.7% | 0.01% | -30.0% |
| Q1 2021 | $20,858,000 | +4.2% | 1,126,902 | -0.5% | 0.01% | +11.1% |
| Q4 2020 | $20,019,000 | +16.9% | 1,132,948 | +1.3% | 0.01% | 0.0% |
| Q3 2020 | $17,132,000 | – | 1,118,261 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |